New study from our member, Ghent University. Porcine Reproductive and Respiratory Syndrome …
MEASLES ON THE RISE IN EUROPE (AGAIN)
‘One of the most highly contagious diseases on the planet is spreading …
MEMBER NEWS: Ghent University and CEPI are working together on innovative ‘spin freezing’ technology for mRNA vaccines
Scientists at Ghent University will receive up to $1.9 million in funding …
Innovations to Prepare for Future Epidemics and Pandemics
Vaccine development and manufacturing Innovations to Prepare for Future Epidemics and Pandemics …
White paper: Prioritizing Safety in CAR-T Therapy: Patient Monitoring with Cerba Research’s Testing Portfolio
In the ever-evolving landscape of healthcare, Cell and Gene Therapy …
IABS/Flanders Vaccine meeting Report: The role of real-world evidence for regulatory and public health decision-making for Accelerated Vaccine Deployment
On September 19 & 20, 2023, the IABS/ Flanders Vaccine meeting on …
Osivax Announces Vaccination of First Participant in First-in-Human Trial Evaluating Sarbecovirus Vaccine Candidate OVX033
Phase 1 study to evaluate safety and immunogenicity of sarbecovirus (coronavirus) vaccine …
MEMBER NEWS: Researchers at UAntwerp are developing a new therapy against pancreatic and colon cancer
Scientists from the University of Antwerp are developing a new treatment against pancreatic …
Can phage therapy help us in the fight against antibiotic resistance?
By Emer Cooke – Executive Director of the European Medicines Agency Bacteria …
Combinatorial Screening of Biscarbamate Ionizable Lipids Identifies a Low Reactogenicity Lipid for Lipid Nanoparticle mRNA Delivery
New publication to which our members, eTheRNA and University of Ghent contributed. This …